Login
$AGIG
$1.01 +$0.00 (0.0%) Close

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q2 FY2026
As of Jun 30, 2026
Q1 FY2026
As of Mar 31, 2026
Q4 FY2025
As of Dec 31, 2025
Q3 FY2025
As of Sep 30, 2025
Q2 FY2025
As of Jun 30, 2025
Q1 FY2025
As of Mar 31, 2025
Q4 FY2024
As of Dec 31, 2024
Q3 FY2024
As of Sep 30, 2024
Q2 FY2024
As of Jun 30, 2024
Q1 FY2024
As of Mar 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q3 FY2023
As of Sep 30, 2023
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q4 FY2021
As of Dec 31, 2021
Q3 FY2021
As of Sep 30, 2021
ASSETS
CURRENT ASSETS
Cash and cash equivalents
Accounts receivable, net
Government grant receivable
Contract Assets
Prepaid expenses
Other current assets
TOTAL CURRENT ASSETS
Land
Other property and equipment, net
Costs subject to amortization
Costs not being amortized
Office equipment
Accumulated depletion, depreciation, amortization, and impairment
Total
PROPERTY AND EQUIPMENT, NET
Equity investment – Hupecol Meta LLC
Refundable acquisition deposit
Capitalized patents
Deposits on license agreements
Goodwill
Technology licenses
Capitalized patents, net
Operating lease right of use asset
Other assets
TOTAL OTHER ASSETS
TOTAL ASSETS
LIABILITIES AND SHAREHOLDERS’ EQUITY
CURRENT LIABILITIES
Accounts payable
Accrued expenses
Accounts payable and accrued liabilities
Deferred revenue
Notes payable – related party, net
Convertible note payable
HUSA Convertible Note Payable
Abundia Global Impact Group LLC
Total convertible note payable
Note payable – related party
Related Party
Total note payable – related party
Convertible note payable measured at fair value- related party
Current portion of lease liability
Warrant liabilities
Other payables
TOTAL CURRENT LIABILITIES
LONG-TERM LIABILITIES
AGIG convertible note payable
Convertible note payable
Operating lease liability, net of current portion
Asset retirement obligation
TOTAL LONG-TERM LIABILITIES
TOTAL LIABILITIES
SHAREHOLDERS’ EQUITY
Common stock, par value $0.001 per share; 300,000,000 shares authorized: 44,150,321 and 36,918,281 shares issued and outstanding as of June 30, 2026, and December 31, 2025, respectively
Additional paid-in capital
Equity in RPD prior to acquisition
Non-controlling interest
Accumulated deficit
TOTAL SHAREHOLDERS’ EQUITY/(DEFICIT)
Other comprehensive income (loss)
Noncontrolling interest in consolidated subsidiary
TOTAL SHAREHOLDERS’ EQUITY
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support